Vitality Watch

Dossier clinicaltrials trial early 25-jun-2026
Small or early-phase human trial or pilot study

Clinical Trial to Evaluate the Efficacy of Neuromuscular Electrical Stimulation Therapy in Patients With Sarcopenia

Key claim: An exploratory clinical trial is testing whether 8 weeks of home-based neuromuscular electrical stimulation (NMES) to both thighs at least four times per week can safely improve lower-extremity strength and physical performance in patients with sarcopenia.

Abstract

The goal of this clinical trial is to exploratorily evaluate the safety and efficacy of a home-based lower extremity muscle strengthening and physical performance enhancement program using Neuromuscular Electrical Stimulation (NMES) devices.

Participants will apply NMES stimulation to both thighs for 8 weeks, at a frequency of at least 4 times per week.

Why this matters

An exploratory clinical trial is testing whether 8 weeks of home-based neuromuscular electrical stimulation (NMES) to both thighs at least four times per week can safely improve lower-extremity strength and physical performance in patients with sarcopenia.

Source

Link

Briefing card

Clinical Trial to Evaluate the Efficacy of Neuromuscular Electrical Stimulation Therapy in Patients With Sarcopenia
Stage: trial early · clinicaltrials · 25-jun-2026

An exploratory clinical trial is testing whether 8 weeks of home-based neuromuscular electrical stimulation (NMES) to both thighs at least four times per week can safely improve lower-extremity strength and physical performance in patients with sarcopenia.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07668258

build build 880 · 2bcef25 · 2026-11-18